Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.98K Sell
28
-8
-22% -$969 ﹤0.01% 2177
2026
Q1
$5.89K Buy
36
+12
+50% +$1.84K ﹤0.01% 2070
2025
Q4
$4.18K Sell
24
-355
-94% -$64.8K ﹤0.01% 2243
2025
Q3
$54.6K Sell
379
-195
-34% -$23.9K ﹤0.01% 1300
2025
Q2
$57K Sell
574
-69
-11% -$5.28K ﹤0.01% 1262
2025
Q1
$49K Buy
+643
New +$49.2K ﹤0.01% 1171
2024
Q4
Sell
-771
Closed -$56K 1659
2024
Q3
$56K Hold
771
﹤0.01% 1139
2024
Q2
$51K Sell
771
-172
-18% -$6.67K ﹤0.01% 1138
2024
Q1
$25K Buy
943
+105
+13% +$2.94K ﹤0.01% 1375
2023
Q4
$25K Hold
838
﹤0.01% 1391
2023
Q3
$21K Buy
+838
New +$19.2K ﹤0.01% 1431

Other funds holding INSM

NBC Securities's INSM Position: Q2 2026 in Review

NBC Securities reduced its Insmed (INSM) stake by 22% in Q2 2026, selling an estimated $969 and leaving 28 shares worth $2.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2177.

NBC Securities first reported a position in INSM in Q3 2023 and has held it in 11 quarters since. The position peaked at $57K in Q2 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • NBC Securities held 28 shares of Insmed worth $2.98K as of Q2 2026.
  • NBC Securities sold 8 Insmed shares in Q2 2026, an estimated $969.
  • Insmed made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #2177 holding.
  • NBC Securities first reported a position in Insmed in Q3 2023 and has held it in 11 quarters since.
  • NBC Securities's Insmed position peaked at $57K in Q2 2025.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.